Mediolanum International Funds »

United Therapeutics Corporation shares owned by Mediolanum International Funds

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Mediolanum International Funds from 13F filings

Historical chart of Mediolanum International Funds investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Mediolanum International Funds consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Mediolanum International Funds

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.3M 5.2k 243.27

More positions owned by Mediolanum International Funds

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Alphabet Inc -a- Cap Stk Cl A (GOOGL)
Alphabet Inc -c- Cap Stk Cl C (GOOG)
Meta Platforms Registerd Shs A Cl A (META)
UnitedHealth (UNH)
Amazon (AMZN)
Merck & Co (MRK)
Applied Materials (AMAT)
Adobe Systems Incorporated (ADBE)
Exxon Mobil Corporation (XOM)
Accenture Plc Ireland Shs Class A (ACN)
salesforce (CRM)
Broadcom (AVGO)

View all positions for Mediolanum International Funds

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
Wellington Management Company
venBio Select Advisor
FMR
AQR Capital Management
Geode Capital Management
Citadel Advisors
Citigroup
Henderson Group
Hanna Zanoni
Dimensional Fund Advisors
Morgan Stanley
LSV Asset Management
Pacer Advisors

View all funds holding United Therapeutics Corporation